. 2021 Sep 15;8(6):e1068. doi: 10.1212/NXI.0000000000001068
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Table 1.
Cohort Description for AQP4-IgG–Seropositive Patients With NMOSD and HCs
